Merit Financial Group’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
Merit Financial Group's KURA Position: Q3 2026 in Review
Merit Financial Group increased its Kura Oncology (KURA) stake by 34% in Q3 2026, buying an estimated $88.6K and bringing the position to 31,197 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.
Merit Financial Group first reported a position in KURA in Q3 2025 and has held it in 5 quarters since. 229 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- Merit Financial Group held 31,197 shares of Kura Oncology worth $334K as of Q3 2026.
- Merit Financial Group bought 7,920 Kura Oncology shares in Q3 2026, an estimated $88.6K.
- Kura Oncology made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1839 holding.
- Merit Financial Group first reported a position in Kura Oncology in Q3 2025 and has held it in 5 quarters since.
- 229 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.